The nuclear receptor retinoic acid-related orphan receptor-Ī± (RORĪ±) regulates numerous critical biological processes, including central nervous system development, lymphocyte differentiation, and lipid metabolism. RORĪ± has been recently identified in the heart, but very little is known about its role in cardiac physiology. We sought to determine whether RORĪ± regulates myocardial hypertrophy and cardiomyocyte survival in the context of angiotensin II (ANG II) stimulation. For in vivo characterization of the function of RORĪ± in the context of pathological cardiac hypertrophy and heart failure, we used the āstaggererā (RORĪ±sg/sg) mouse, which harbors a germline mutation encoding a truncated and globally nonfunctional RORĪ±. RORĪ±sg/sg and wild-type littermate mice were infused with ANG II or vehicle for 14 days. For in vitro experiments, we overexpressed or silenced RORĪ± in neonatal rat ventricular myocytes (NRVMs) and human cardiac fibroblasts exposed to ANG II. RORĪ±sg/sg mice developed exaggerated myocardial hypertrophy and contractile dysfunction after ANG II treatment. In vitro gain- and loss-of-function experiments were consistent with the discovery that RORĪ± inhibits ANG II-induced pathological hypertrophy and cardiomyocyte death in vivo. RORĪ± directly repressed IL-6 transcription. Loss of RORĪ± function led to enhanced IL-6 expression, proinflammatory STAT3 activation (phopho-STAT3 Tyr705), and decreased mitochondrial number and function, oxidative stress, hypertrophy, and death of cardiomyocytes upon ANG II exposure. RORĪ± was less abundant in failing compared with nonfailing human heart tissue. In conclusion, RORĪ± protects against ANG II-mediated pathological hypertrophy and heart failure by suppressing the IL-6-STAT3 pathway and enhancing mitochondrial function. NEW & NOTEWORTHY Mice lacking retinoic acid-related orphan receptor-Ī± (RORĪ±) develop exaggerated cardiac hypertrophy after angiotensin II infusion. Loss of RORĪ± leads to enhanced IL-6 expression and NF-ĪŗB nuclear translocation. RORĪ± maintains mitochondrial function and reduces oxidative stress after angiotensin II. The abundance of RORĪ± is reduced in failing mouse and human hearts.